RecruitingNot ApplicableNCT06711822

The Safety and Performence of ShockPulse-10 in Patients with Coronary Artery Calcification

Prospective, Multicenter, Single-group Clinical Trial Evaluating the Safety and Effectiveness of ShockPulse-10 in the Treatment of Coronary Artery Calcification

Sponsor

Keya Medical

Enrollment

205 participants

Start Date

Jul 1, 2024

Study Type

INTERVENTIONAL

Conditions

Coronary Arterial Disease (CAD)Calcification; Heart

Summary

This study is an exploratory, multicenter, single-group clinical trial aimed to evaluate the clinical outcomes of using ShockPulse-10 in the treatment of coronary artery calcification .

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Shockplus-10 for people with calcification; heart and coronary arterial disease (cad). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.